Cengild Medical Berhad (0243) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cengild Medical Berhad (0243) has a cash flow conversion efficiency ratio of 0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM947.00K ≈ $237.76K USD) by net assets (RM116.98 Million ≈ $29.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Cengild Medical Berhad (0243) strategic investment index to assess the company's strategic physical and investment asset allocation.
Cengild Medical Berhad - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data. See 0243 net assets for net asset value and shareholders' equity analysis.
Cengild Medical Berhad Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cengild Medical Berhad ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fuel Tech Inc
NASDAQ:FTEK
|
-0.022x |
|
Unibios Holdings S.A
AT:BIOSK
|
0.021x |
|
Baltic Sea Properties AS
OL:BALT
|
0.027x |
|
NexLiving Communities Inc
V:NXLV
|
0.062x |
|
Full Wang International Development Co Ltd
TWO:6219
|
-0.287x |
|
PB Bankshares Inc
NASDAQ:PBBK
|
0.015x |
|
Guler Yatirim Holding AS
IS:GLRYH
|
0.065x |
|
Freja eID Group AB
ST:FREJA
|
0.075x |
Annual Cash Flow Conversion Efficiency for Cengild Medical Berhad (2020–2025)
The table below shows the annual cash flow conversion efficiency of Cengild Medical Berhad from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see 0243 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | RM114.46 Million ≈ $28.74 Million |
RM16.08 Million ≈ $4.04 Million |
0.140x | +20.87% |
| 2024-06-30 | RM111.30 Million ≈ $27.94 Million |
RM12.94 Million ≈ $3.25 Million |
0.116x | -10.39% |
| 2023-06-30 | RM106.11 Million ≈ $26.64 Million |
RM13.76 Million ≈ $3.46 Million |
0.130x | -14.22% |
| 2022-06-30 | RM92.95 Million ≈ $23.34 Million |
RM14.05 Million ≈ $3.53 Million |
0.151x | -85.43% |
| 2021-06-30 | RM13.78 Million ≈ $3.46 Million |
RM14.30 Million ≈ $3.59 Million |
1.038x | -9.62% |
| 2020-06-30 | RM9.79 Million ≈ $2.46 Million |
RM11.24 Million ≈ $2.82 Million |
1.148x | -- |
About Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more